Improving language function in patients with Primary Progressive Aphasia
Official title: Enhancing Language Function in Primary Progressive Aphasia (PPA) With Transcranial Direct Current Stimulation (tDCS)
Run by University of Arizona · NCT04920318 · Data updated 2026-11-12
This study is testing whether a new treatment that combines brain stimulation with language therapy can help people with Primary Progressive Aphasia improve their language skills.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 80 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Arizona Academic / other |
| Locations | 1 site (Tucson, Arizona) |
| Status | Recruiting |
| Started | August 30, 2021 |
| Main results expected | December 30, 2026 |
| Study ends | June 15, 2027 |
| Registry record updated | November 29, 2024 |
| Trial ID | NCT04920318 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with Primary Progressive Aphasia who exhibit speech-language deficits.
✕Probably not a fit
Patients with other neurological disorders, severe systemic diseases, or contraindications for MRI may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance language abilities in individuals diagnosed with Primary Progressive Aphasia (PPA) using non-invasive brain stimulation techniques, specifically transcranial direct current stimulation (tDCS), combined with behavioral language therapy. The approach focuses on stimulating specific brain regions that are structurally preserved but functionally impaired due to the neurodegenerative nature of PPA. By utilizing functional magnetic resonance imaging (fMRI) to identify targeted areas for stimulation, the study seeks to optimize electrode placement for each participant. The goal is to assess both short- and long-term effects of this combined intervention on language function.
Why it matters
Potential benefit: If successful, this approach could significantly improve language capabilities in patients suffering from Primary Progressive Aphasia.
How similar studies have gone: While tDCS has shown promise in other neurological conditions, its application in Primary Progressive Aphasia is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * diagnosed with PPA by neurologist or speech-language pathologist * speech-language deficit arising from PPA * native speaker of English Language or equivalent * adequate vision (normal or corrected to normal) * adequate hearing Exclusion Criteria: * meeting (Diagnostic and Statistical Manual) DSM-IV criteria for Axis I mood, anxiety, psychotic or substance abuse disorders. * highly magnetizable metallic implants, including certain dental work * neurological disorders besides the ones of interest for the study (e.g., epilepsy) * Multiple Sclerosis * Parkinson's Disease * contraindications for MRI * pacemakers * metallic cardiac pumps * valves * magnetic materials such as surgical clips, implanted electronic perfusion pumps, or any other condition that would preclude proximity to a strong magnetic field. * clinically significant claustrophobia * severe systemic disease (e.g., renal failure) * poor health * pregnancy * epileptic activity in the past 12 months * family history of epilepsy or other seizure disorders * brain surgery in the past * metallic skull plates or implants * skin lesions or skull damage * excessive use of alcohol or drugs * premorbid psychiatric disease affecting communication * severe non-linguistic cognitive disturbances impeding language therapy
Where it's running
-
University of Arizona
Tucson, Arizona, United States Recruiting
Study contacts
- Principal investigator: Aneta Kielar, PhD — University of Arizona
- Study coordinator: Aneta Kielar, PhD
- Email: akielar@email.arizona.edu
- Phone: 15204883791
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Stimulating the aging brain with brain and sensory stimulation for language), wait
This study tests whether transcranial alternating current stimulation (tACS) and multisensory stimulation can improve verbal short-term memory in people with Primary Progressive Aphasia.
-
Predicting disease progression in dementia using biomarkers and modeling
This study is trying to create a tool that helps predict how dementia will progress in people with mild cognitive impairment and different types of dementia, like Alzheimer's and Lewy Body Disease, by looking at brain scans, body fluids, and mental tests.
-
Educational support program for bilingual individuals with progressive aphasia and their caregivers
This study is testing a support program for bilingual people with progressive aphasia and their caregivers to see if it helps them communicate better and cope with the challenges of the condition.
-
Evaluating speech therapy for Primary Progressive Aphasia
This study is testing if speech therapy and a special app can help adults with mild to moderate Primary Progressive Aphasia communicate better.
-
Effects of speech-language intervention on bilingual speakers with primary progressive aphasia
This study tests if special speech therapy designed for bilingual people can help those with primary progressive aphasia communicate better in both of their languages.
-
Improving language skills in people with aphasia
This study is testing a new language treatment for people with aphasia to see if it helps them improve their speaking and understanding skills.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.